Trial NCT02693717

View at ClinicalTrials.gov 
Org. Study IDs: 2015-0592
Secondary IDs: 2015-0592 NCI-2016-00390 P30CA016672

Last trial update was posted on 2021-05-20

MeSH Interventions

Pemetrexed

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell

Other Conditions

Metastatic Urothelial Carcinoma

Stopping Reasons

The trial was closed due to the changing efficacy of treatments for metastatic urothelial cancer.

Limitations And Caveats

This protocol was stopped early as it was considered unethical. A new protocol with the same study drugs plus an immune check point drug was added. There is no data to report.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID